Tag: Mydecine - Page 9 - Psychedelic Alpha

Read more about the article Mydecine Innovations Group Announces Extended Lock-Up Arrangement

Mydecine Innovations Group Announces Extended Lock-Up Arrangement

Post published:August 25, 2020
Post category:Press Release

Read more about the article Mydecine™ Launches World’s First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise

Mydecine™ Launches World’s First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise

Post published:August 18, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD

Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD

Post published:August 13, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector

Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector

Post published:August 12, 2020
Post category:Press Release

Read more about the article Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness

Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness

Post published:August 4, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

Post published:July 25, 2020
Post category:Press Release

Read more about the article Mindleap Health Signs Agreement with Brightmind to Launch Comprehensive Meditation Program

Mindleap Health Signs Agreement with Brightmind to Launch Comprehensive Meditation Program

Post published:July 21, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute

Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute

Post published:July 16, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

Post published:July 14, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Adds World Renowned, 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to its Scientific Advisory Board

Mydecine Innovations Group Adds World Renowned, 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to its Scientific Advisory Board

Post published:July 7, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.